{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:43:45Z","timestamp":1777491825581,"version":"3.51.4"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T00:00:00Z","timestamp":1451347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144660","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T18:46:45Z","timestamp":1451414805000},"page":"e0144660","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice"],"prefix":"10.1371","volume":"10","author":[{"given":"Michael S.","family":"Boosalis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose I.","family":"Sangerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman F.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levi H.","family":"Makala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biaoru","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty S.","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Nouraie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas V.","family":"Faller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan P.","family":"Perrine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,29]]},"reference":[{"key":"ref1","first-page":"4331","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"115","author":"DJ Weatherall","year":"2010"},{"issue":"6","key":"ref2","first-page":"e818","article-title":"Changes in the epidemiology of thalassemia in North America: a new minority disease","volume":"116","author":"EP Vichinsky","year":"2005"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00005792-200109000-00007","article-title":"Pharmacologic modulation of fetal hemoglobin","volume":"80","author":"MH Steinberg","year":"2001","journal-title":"Medicine"},{"key":"ref4","first-page":"3945","article-title":"Transcriptional regulation of fetal to adulthemoglobin switching: new therapeutic opportunities","volume":"117","author":"A Wilbur","year":"2011"},{"issue":"15","key":"ref5","first-page":"2945","article-title":"Reawakening fetal hemoglobin: prospects for new therapies for the beta- globin disorders","volume":"120","author":"DE Bauer","year":"2012"},{"key":"ref6","first-page":"233","article-title":"Emerging therapy in hemoglobinopathies: lessons from the past and optimism for the future. Hematol Oncol Clin North Am","author":"SP Perrine","year":"2014"},{"key":"ref7","first-page":"1639","article-title":"Mortalityin sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"OS Platt","year":"1994"},{"key":"ref8","first-page":"403","article-title":"Therisks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up","volume":"85","author":"MH Steinberg","year":"2010"},{"key":"ref9","first-page":"75","article-title":"Pathobiology of thalassemic erythrocytes","volume":"4","author":"SL Schrier","year":"1997"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overviewon practices in thalassemia intermedia management aiming for lowering complicationsrates across a region of endemicity: the Optimal Care Study","volume":"11","author":"AT Taher","year":"2010","journal-title":"Blood"},{"key":"ref11","first-page":"318","article-title":"Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models","volume":"67","author":"R Bohacek","year":"2006"},{"key":"ref12","first-page":"466","article-title":"Erythroid Kruppel-like factor (EKLF) is recruited to the gamma-globin gene promoter as a co-activatorand is required for gamma-globin gene induction by short-chain fatty acid derivatives","volume":"82","author":"SP Perrine","year":"2009"},{"key":"ref13","first-page":"3179","article-title":"Short-chain fatty acids induce gamma-globin gene expression by displacement of aHDAC3-NCoR repressor complex","volume":"108","author":"R Mankidy","year":"2006"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood.V74.6.1963.1963","article-title":"On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC","volume":"74","author":"P Constantoulakis","year":"1989","journal-title":"Blood"},{"key":"ref15","first-page":"4640","article-title":"Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo","volume":"100","author":"BS Pace","year":"2002"},{"key":"ref16","first-page":"3259","article-title":"Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation","volume":"97","author":"MS Boosalis","year":"2001"},{"key":"ref17","article-title":"The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell disease","author":"S Cui","year":"2015","journal-title":"Blood"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"e107006","DOI":"10.1371\/journal.pone.0107006","article-title":"A cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathies","volume":"9","author":"KR Peterson","year":"2014","journal-title":"PloS One"},{"key":"ref19","first-page":"100","article-title":"Compounds of the anthracycline family of antibiotics elevate human \u03b3-globin expression both in erythroid cultures and in a transgenic mouse model","volume":"44","author":"P Spyrou","year":"2010"},{"issue":"14","key":"ref20","first-page":"4428","article-title":"5-azacytidine stimulates fetal hemoglobin synthesis in anemic baboons","volume":"79","author":"J DeSimone","year":"1982"},{"key":"ref21","first-page":"81","article-title":"A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders","volume":"328","author":"SP Perrine","year":"1993"},{"key":"ref22","first-page":"43","article-title":"Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial","volume":"85","author":"AF Collins","year":"1995"},{"key":"ref23","first-page":"1790","article-title":"Sustainedinduction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease","volume":"93","author":"GF Atweh","year":"1999"},{"key":"ref24","first-page":"737","article-title":"Induction of fetal hemoglobin synthesis in children with sickle cell anemia on low-dose oral sodium phenylbutyrate therapy","volume":"24","author":"LM Resar","year":"2002"},{"key":"ref25","first-page":"555","article-title":"Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitroand in vivo","volume":"88","author":"SP Perrine","year":"1994"},{"issue":"2","key":"ref26","first-page":"1317","article-title":"Effect of hydroxyurea on frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia","volume":"332","author":"S Charache","year":"1995"},{"key":"ref27","first-page":"1663","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomized, controlled trial (BABY HUG)","volume":"377","author":"WC Wang","year":"2011"},{"key":"ref28","first-page":"3865","article-title":"Effects of 5- aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease","volume":"102","author":"Y Saunthararajah","year":"2003"},{"issue":"4","key":"ref29","first-page":"587","article-title":"A randomized Phase I\/II trial of HQK-1001, an oral foetal globin gene inducer, in beta thalassemia intermedia and HbE beta thalassemia","volume":"161","author":"S Fuchareon","year":"2013"},{"issue":"11","key":"ref30","first-page":"E255","article-title":"A dose escalation phase IIa study of 2, 2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle celldisease","author":"A Kutlar","year":"2013"},{"issue":"12","key":"ref31","first-page":"1956","article-title":"Aphase 2 trial in HQK-1001 in HBE-\u03b2 thalassemia demonstrates HBF induction and reduced anemia","volume":"123","author":"P Patthamalai","year":"2014"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/bcmd.2000.0283","article-title":"Oral isobutyramide therapy in patients with thalassemia intermedia: results of a phase II open study","volume":"26","author":"MD Cappelini","year":"2000","journal-title":"Blood Cells, Mols, Dis"},{"key":"ref33","first-page":"3357","article-title":"Oral isobutyramidereduces transfusion requirements in some patients with homozygous beta thalassemia","volume":"96","author":"S Reich","year":"2000"},{"key":"ref34","first-page":"807","article-title":"Sirtuin 1 is required for an antagonist induced transcriptional repression of androgen responsive genes by the androgen receptor","volume":"21","author":"Y Dai","year":"2007","journal-title":"Mol Endocrinol"},{"key":"ref35","first-page":"1057","article-title":"A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger","volume":"36","author":"R Mabaera","year":"2008"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1182\/blood-2006-08-041830","article-title":"Regulation of protein synthesis by the heme-regulated eIF2\u03b1 kinase: relevance to anemias","volume":"109","author":"J-J Chen","year":"2007","journal-title":"Blood"},{"key":"ref37","first-page":"214","article-title":"Multiple physical stresses induce \u03b3-globin gene expression and fetal hemoglobin production in erythroid cells","volume":"52","author":"EK Schaeffer","year":"2014"},{"issue":"28","key":"ref38","first-page":"12617","article-title":"Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease","volume":"107","author":"JE Bradner","year":"2010"},{"key":"ref39","first-page":"505","article-title":"Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies","volume":"88","author":"U Testa","year":"2009"},{"key":"ref40","unstructured":"Hoffman-La Roche Limited. Product Monograph levodopa and benserazide combination Capsules 50\u201312.5, 100\u201325, 200\u201350 Pharmaceutical standard: professed Antiparkinson Agent. Submission control No. 128706. Available: http:\/\/www.rochecanada.com\/fmfiles\/re7234008\/Research\/ClinicalTrialsForms\/Products\/ConsumerInformation\/MonographsandPublicAdvisories\/ProlopaPME.pdf<\/ext-link>. Accessed 2014 August 22."},{"key":"ref41","first-page":"144","article-title":"BCL11A represses HBG transcription in K562 cells","volume":"42","author":"Z Chen","year":"2009"},{"key":"ref42","first-page":"2111","article-title":"Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients","volume":"82","author":"D Labie","year":"1985"},{"key":"ref43","first-page":"455","article-title":"Discovering the genetics underlying foetal haemoglobin production in adults","volume":"145","author":"SL Thein","year":"2009"},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.23457","article-title":"Genetic modifiers of sickle cell anemia in the Baby HUG cohort: influence on laboratory and clinical phenotypes","author":"VA Sheehan","year":"2013"},{"key":"ref45","first-page":"1620","article-title":"Genome-wideassociation study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia","volume":"105","author":"M Uda","year":"2008"},{"key":"ref46","first-page":"303","article-title":"A genome-wide association identified the common genetic variants influence disease severity in beta 0-thalassemia\/hemoglobin","volume":"127","author":"M Nuinoon","year":"2010"},{"issue":"33","key":"ref47","first-page":"11869","article-title":"DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta- globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease","volume":"105","author":"G Lettre","year":"2008"},{"key":"ref48","first-page":"803","article-title":"KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of \u03b2-thalassemia","volume":"124","author":"D Liu","year":"2014"},{"key":"ref49","first-page":"672","article-title":"KLF1: when less is more","volume":"124","author":"D Manwani","year":"2014"},{"key":"ref50","first-page":"435","article-title":"Regulation of human fetal hemoglobin: new players, new complexities","volume":"107","author":"A Bank","year":"2006"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T09:46:50Z","timestamp":1599990410000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144660"}},"subtitle":[],"editor":[{"given":"Andrew C.","family":"Wilber","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,29]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144660","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,29]]}}}